A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons

John M. Colford, Sona R. Saha, Timothy J. Wade, Catherine C. Wright, Mai Vu, Sandra Charles, Peter Jensen, Alan Hubbard, Deborah A Levy, Joseph N.S. Eisenberg

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Although immunocompromised persons may be at increased risk for gastrointestinal illnesses, no trials investigating drinking water treatment and gastrointestinal illness in such patients have been published. Earlier results from San Francisco suggested an association (OR 6.76) between tap water and cryptosporidiosis among HIV + persons. The authors conducted a randomized, triple-blinded intervention trial of home water treatment in San Francisco, California, from April 2000 to May 2001. Fifty HIV-positive patients were randomized to externally identical active (N = 24) or sham (N = 26) treatment devices. The active device contained a filter and UV light; the sham provided no treatment. Forty-five (90%) of the participants completed the study and were successfully blinded. Illness was measured using 'highly credible gastrointestinal illness' (HCGI), a previously published measure. There were 31 episodes of HCGI during 1,797 person-days in the sham group and 16 episodes during 1,478 person-days in the active group. The adjusted relative risk was 3.34 (95% CI: 0.99-11.21) times greater in those with the sham device. The magnitude of the point estimate of the risk, its consistency with recently published observational data, and its relevance for drinking water choices by immunocompromised individuals support the need for larger trials.

Original languageEnglish (US)
Pages (from-to)173-184
Number of pages12
JournalJournal of Water and Health
Volume3
Issue number2
StatePublished - Jan 1 2005

Fingerprint

human immunodeficiency virus
Drinking Water
Randomized Controlled Trials
drinking water
HIV
San Francisco
Water Purification
Equipment and Supplies
Cryptosporidiosis
water treatment
Ultraviolet Rays
filter
trial
Water
Therapeutics
water

Keywords

  • Drinking water quality
  • Gastroenteritis
  • HIV
  • Randomized trial
  • Triple blinding

ASJC Scopus subject areas

  • Water Science and Technology
  • Waste Management and Disposal
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Colford, J. M., Saha, S. R., Wade, T. J., Wright, C. C., Vu, M., Charles, S., ... Eisenberg, J. N. S. (2005). A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons. Journal of Water and Health, 3(2), 173-184.

A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons. / Colford, John M.; Saha, Sona R.; Wade, Timothy J.; Wright, Catherine C.; Vu, Mai; Charles, Sandra; Jensen, Peter; Hubbard, Alan; Levy, Deborah A; Eisenberg, Joseph N.S.

In: Journal of Water and Health, Vol. 3, No. 2, 01.01.2005, p. 173-184.

Research output: Contribution to journalArticle

Colford, JM, Saha, SR, Wade, TJ, Wright, CC, Vu, M, Charles, S, Jensen, P, Hubbard, A, Levy, DA & Eisenberg, JNS 2005, 'A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons', Journal of Water and Health, vol. 3, no. 2, pp. 173-184.
Colford JM, Saha SR, Wade TJ, Wright CC, Vu M, Charles S et al. A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons. Journal of Water and Health. 2005 Jan 1;3(2):173-184.
Colford, John M. ; Saha, Sona R. ; Wade, Timothy J. ; Wright, Catherine C. ; Vu, Mai ; Charles, Sandra ; Jensen, Peter ; Hubbard, Alan ; Levy, Deborah A ; Eisenberg, Joseph N.S. / A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons. In: Journal of Water and Health. 2005 ; Vol. 3, No. 2. pp. 173-184.
@article{dfe3c8d837044f99b45f332435864dd1,
title = "A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons",
abstract = "Although immunocompromised persons may be at increased risk for gastrointestinal illnesses, no trials investigating drinking water treatment and gastrointestinal illness in such patients have been published. Earlier results from San Francisco suggested an association (OR 6.76) between tap water and cryptosporidiosis among HIV + persons. The authors conducted a randomized, triple-blinded intervention trial of home water treatment in San Francisco, California, from April 2000 to May 2001. Fifty HIV-positive patients were randomized to externally identical active (N = 24) or sham (N = 26) treatment devices. The active device contained a filter and UV light; the sham provided no treatment. Forty-five (90{\%}) of the participants completed the study and were successfully blinded. Illness was measured using 'highly credible gastrointestinal illness' (HCGI), a previously published measure. There were 31 episodes of HCGI during 1,797 person-days in the sham group and 16 episodes during 1,478 person-days in the active group. The adjusted relative risk was 3.34 (95{\%} CI: 0.99-11.21) times greater in those with the sham device. The magnitude of the point estimate of the risk, its consistency with recently published observational data, and its relevance for drinking water choices by immunocompromised individuals support the need for larger trials.",
keywords = "Drinking water quality, Gastroenteritis, HIV, Randomized trial, Triple blinding",
author = "Colford, {John M.} and Saha, {Sona R.} and Wade, {Timothy J.} and Wright, {Catherine C.} and Mai Vu and Sandra Charles and Peter Jensen and Alan Hubbard and Levy, {Deborah A} and Eisenberg, {Joseph N.S.}",
year = "2005",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "173--184",
journal = "Journal of Water and Health",
issn = "1477-8920",
publisher = "IWA Publishing",
number = "2",

}

TY - JOUR

T1 - A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons

AU - Colford, John M.

AU - Saha, Sona R.

AU - Wade, Timothy J.

AU - Wright, Catherine C.

AU - Vu, Mai

AU - Charles, Sandra

AU - Jensen, Peter

AU - Hubbard, Alan

AU - Levy, Deborah A

AU - Eisenberg, Joseph N.S.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Although immunocompromised persons may be at increased risk for gastrointestinal illnesses, no trials investigating drinking water treatment and gastrointestinal illness in such patients have been published. Earlier results from San Francisco suggested an association (OR 6.76) between tap water and cryptosporidiosis among HIV + persons. The authors conducted a randomized, triple-blinded intervention trial of home water treatment in San Francisco, California, from April 2000 to May 2001. Fifty HIV-positive patients were randomized to externally identical active (N = 24) or sham (N = 26) treatment devices. The active device contained a filter and UV light; the sham provided no treatment. Forty-five (90%) of the participants completed the study and were successfully blinded. Illness was measured using 'highly credible gastrointestinal illness' (HCGI), a previously published measure. There were 31 episodes of HCGI during 1,797 person-days in the sham group and 16 episodes during 1,478 person-days in the active group. The adjusted relative risk was 3.34 (95% CI: 0.99-11.21) times greater in those with the sham device. The magnitude of the point estimate of the risk, its consistency with recently published observational data, and its relevance for drinking water choices by immunocompromised individuals support the need for larger trials.

AB - Although immunocompromised persons may be at increased risk for gastrointestinal illnesses, no trials investigating drinking water treatment and gastrointestinal illness in such patients have been published. Earlier results from San Francisco suggested an association (OR 6.76) between tap water and cryptosporidiosis among HIV + persons. The authors conducted a randomized, triple-blinded intervention trial of home water treatment in San Francisco, California, from April 2000 to May 2001. Fifty HIV-positive patients were randomized to externally identical active (N = 24) or sham (N = 26) treatment devices. The active device contained a filter and UV light; the sham provided no treatment. Forty-five (90%) of the participants completed the study and were successfully blinded. Illness was measured using 'highly credible gastrointestinal illness' (HCGI), a previously published measure. There were 31 episodes of HCGI during 1,797 person-days in the sham group and 16 episodes during 1,478 person-days in the active group. The adjusted relative risk was 3.34 (95% CI: 0.99-11.21) times greater in those with the sham device. The magnitude of the point estimate of the risk, its consistency with recently published observational data, and its relevance for drinking water choices by immunocompromised individuals support the need for larger trials.

KW - Drinking water quality

KW - Gastroenteritis

KW - HIV

KW - Randomized trial

KW - Triple blinding

UR - http://www.scopus.com/inward/record.url?scp=27144457508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144457508&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 173

EP - 184

JO - Journal of Water and Health

JF - Journal of Water and Health

SN - 1477-8920

IS - 2

ER -